Michael Greco V - 03 Feb 2026 Form 3 Insider Report for Veradermics, Inc (MANE)

Reporting relationship: General Counsel
Issuer ticker: MANE
Reported as of: 03 Feb 2026
Net transaction value: $0
SEC form: 3
Accepted by SEC: 03 Feb 2026, 21:05:31 UTC
Source filing: View source filing
Reporting owner signature: /s/ Michael Greco

Key filing fact

Michael Greco V filed Form 3 for Veradermics, Inc (MANE) on 03 Feb 2026.

Key facts

This page summarizes Michael Greco V's Form 3 filing for Veradermics, Inc (MANE).
0 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 03 Feb 2026, 21:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001786766 Primary reporting owner

Greco Michael V.

Relationship: General Counsel
Address: C/O VERADERMICS, INCORPORATED, 470 JAMES ST., NEW HAVEN
Signature: /s/ Michael Greco
Signature date: 03 Feb 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MANE holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 94,273
Exercise price: $12.19
Footnotes: F1

MANE holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 145,140
Exercise price: $12.79
Footnotes: F2

MANE holding Derivative

Stock Option (Right to Buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 03 Feb 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 35,912
Exercise price: $12.79
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option vests as to 25% of the underlying shares of the Issuer's common stock, par value $0.00001 per share ("Common Stock"), on July 21, 2026, the first anniversary of the vesting commencement date, and vests as to the remaining shares in equal monthly installments over 36 months thereafter, subject to continued service.

Footnote F2

The option will vest as to approximately 19% of the underlying shares of Common Stock as of June 21, 2026, and vests as to the remaining shares in equal monthly installments over 39 months thereafter, subject to continued service.

Footnote F3

This option shall be fully vested and exercisable upon the certification by the Issuer's board of directors (or compensation committee thereof) that the Issuer has achieved a market capitalization of $680.0 million prior to December 31, 2026, subject to the reporting person's continued service. Market capitalization will be measured as the trading price per share of the Issuer's Common Stock on its principal market national stock exchange multiplied by the number of the Issuer's shares of Common Stock issued and outstanding.